digiMedical Solutions, Inc. Announces Appointment of Bill Whitmore to the Board of Advisors

Appointment on the Heels of Recent Sales Team Expansion to Support $10 Million 2008 Revenue Goal


COLLEYVILLE, TX--(Marketwire - April 8, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) today announced that the Company has appointed Bill Whitmore to the Company's Board of Advisors. Mr. Whitmore has nearly 10 years of professional sales experience and is currently a Major Account Manager for Logix Communications Enterprises, Inc., a $105 million dollar, Houston-based telecommunications company. Mr. Whitmore has won numerous sales related awards and consistently ranks among the top 10% in sales for his company.

David Lee, CEO of digiMedical Solutions, stated, "We are excited to be adding Mr. Whitmore to our Board of Advisors. His sales experience will be a great asset, especially with the ongoing expansion of our sales team to aide in meeting our 2008 revenue goal of $10 Million. Our recently expanded sales team has done a great job of signing on new doctors, and Mr. Whitmore's sales expertise will help us take our expansion to the next level by bringing in fresh, innovative sales approaches."

digiMedical Solutions, a Microsoft Partner, with operations in Texas and Florida, has built its own suite of proprietary software to handle prescriptions digitally from the physician's office to the pharmacy, securely and in compliance with all DEA and HIPAA requirements. The suite of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and now digiAccounting and the Company owns and operates five pharmacies throughout Texas and Florida.

Company Information and Updates

To be added to digiMedical's corporate e-mail list for shareholders and interested investors or to receive more information on the company, please send an e-mail to ir@digimedical.com.

About digiMedical Solutions, Inc. ™

digiMedical Solutions, Inc.™ (http://www.digimedical.com) is a pharmacy and medical technology company focused on developing next generation digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that will more closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless base d-prescription technology to doctors, acquisition of independent pharmacy chains and the sale of certain territories to "market partners" licensed to exploit the digiMedical Solutions™ model. digiMedical Solutions, Inc.™ currently owns and operates five (5) pharmacies located in Texas and Florida. digiMedical Solutions'™ unique business model brings doctor, patients and pharmacies into next generation medical technologies.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.

Contact Information: digiMedical Solutions, Inc. Investor Relations ir@digimedical.com 214-722-3029